Health Care & Life Sciences » Biotechnology | Idera Pharmaceuticals Inc.

Idera Pharmaceuticals Inc.

Idera Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.86
Market Cap
$73.14 M
Shares Outstanding
28.02 M
Public Float
22.28 M

Profile

Address
505 Eagleview Boulevard
Exton Pennsylvania 19341
United States
Employees -
Website http://www.iderapharma.com
Updated 07/08/2019
Idera Pharmaceuticals, Inc. is a clinical stage biotechnology company, which focuses on the discovery, development and commercialization of novel oligonucleotide therapeutics for oncology and rare diseases. The firm uses two distinct proprietary drug discovery technology platforms to design and develop drug candidates: Toll-like receptor targeting technology and third-generation antisense technology. The company was founded by Paul C.

Financials

View All

Vincent J. Milano
President, Chief Executive Officer & Director
James A. Geraghty
Chairman